Terry W. Lubben is SVP & Operations at TREACE MEDICAL CONCEPTS, INC. (TMCI). They have made 1 open-market trade across 1 company since 2022, most recently 2022-03-08.
CIK 0001882643
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $47K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TMCI | 3,350 | $13K |
Shares reported on the most recent Form 4, priced at the 2022-03-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TMCI | BUY | 2022-03-08 | 2022-03-10 | $18.62 | $47K | +0.6% | -4.8% | -15.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.